Walleye Trading LLC Avadel Pharmaceuticals PLC Call Options Transaction History

Walleye Trading LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 08, 2022	SELL	$1.07 - $6.95 $4,601 - $29,885	-4,300 Reduced 28.29%	10,900 $27,000
Q1 2022 May 16, 2022	BUY	$5.46 - $8.29 $82,992 - $126,007	15,200 New	15,200 $104,000
Q2 2021 Aug 16, 2021	SELL	$6.73 - $9.05 $55,186 - $74,210	-8,200 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.61 - $10.07 $19,830 - $30,210	3,000 Added 57.69%	8,200 $74,000
Q4 2020 Feb 16, 2021	SELL	$5.03 - $7.95 $201,703 - $318,795	-40,100 Reduced 88.52%	5,200 $35,000
Q3 2020 Nov 16, 2020	BUY	$5.02 - $8.98 $31,123 - $55,676	6,200 Added 15.86%	45,300 $228,000
Q2 2020 Aug 14, 2020	SELL	$7.25 - $11.75 $1.05 Million - $1.7 Million	-144,300 Reduced 78.68%	39,100 $316,000
Q1 2020 May 15, 2020	BUY	$4.06 - $10.64 $534,702 - $1.4 Million	131,700 Added 254.74%	183,400 $1.46 Million
Q4 2019 Feb 14, 2020	BUY	$3.34 - $7.7 $172,678 - $398,090	51,700 New	51,700 $390,000

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $661M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.